iFIT Health & Fitness (IFIT)
(Delayed Data from NSDQ)
$19.50 USD
0.00 (0.00%)
Updated Dec 31, 1969 06:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for iFIT Health & Fitness Inc falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 1,745 | 852 |
Cost Of Goods | NA | NA | NA | 1,019 | 523 |
Gross Profit | NA | NA | NA | 726 | 329 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 0 | 854 | 379 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -128 | -50 |
Non-Operating Income | NA | NA | NA | -356 | -31 |
Interest Expense | NA | NA | NA | 31 | 16 |
Pretax Income | NA | NA | NA | -515 | -96 |
Income Taxes | NA | NA | NA | 2 | 2 |
Minority Interest | NA | NA | NA | 0 | 0 |
Investment Gains/Losses | NA | NA | NA | 0 | 0 |
Other Income/Charges | NA | NA | NA | 0 | 0 |
Income From Cont. Operations | NA | NA | NA | -517 | -99 |
Extras & Discontinued Operations | NA | NA | NA | 0 | 0 |
Net Income (GAAP) | NA | NA | NA | -517 | -99 |
Depreciation Footnote | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | 0 | -95 | -24 |
Depreciation & Amortization (Cash Flow) | NA | NA | NA | 33 | 26 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -128 | -50 |
Earnings Per Share Data | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | -2.32 | NA |
Fiscal Year end for iFIT Health & Fitness Inc falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |